Other
Oxygenation
0
Pipeline Programs↗
5
Active Trials↗
4
Companies Involved↗
Oxygenation is an early-stage landscape with 0 programs across 4 companies. The most active players are Boehringer Ingelheim, Pfizer, Global Blood Therapeutics.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
37
clinical trials
Completed23 · 62%
Unknown status6 · 16%
Recruiting2 · 5%
Withdrawn2 · 5%
Not yet recruiting2 · 5%
Terminated1 · 3%
Other1 · 3%
Clinical Trials
Trial Activity
37 trials
Population Pharmacokinetics of L-AmB in Chinese Patients Assisted by Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
Not yet recruiting·—·Phase 4·NCT06754436·30 enrolled
Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation
Completed·—·Phase 4·NCT03573999·54 enrolled
Fluid Filled Lung Oxygenation Assistance Trial
Completed·—·Phase 1·NCT03041740·16 enrolled
Effect of Magnesium Sulphate Infusion on Lung Mechanics and Oxygenation in COPD Patients Undergoing Total Laryngeal
Completed·—·Phase 4·NCT03461328·40 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)